NCOA3 and cancer: KAT13B/AIB1 (amplified in breast cancer 1) was overexpressed in ESCC in comparison with adjacent normal tissue [44] and its expression was positively associated with advanced clinical stage, distant lymph node metastasis and chemoradiotherapy resistance in ESCC [44,45,46,47].